{"rows":[{"id":2558,"title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.","authors":"Baumeister D, Barnes G, Giaroli G, Tracy D","journal":"Therapeutic advances in psychopharmacology","publication_date":"2014-08-01","publication_year":2014,"doi":"10.1177/2045125314527985","pubmed_id":"25083275","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/25083275/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:25083275","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/25083275/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:25083275","source_url":"https://pubmed.ncbi.nlm.nih.gov/25083275/","doi":"10.1177/2045125314527985","pmid":"25083275","publication_date":"2014-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2547,"title":"Drug models of schizophrenia.","authors":"Steeds H, Carhart-Harris RL, Stone JM","journal":"Therapeutic advances in psychopharmacology","publication_date":"2015-02-01","publication_year":2015,"doi":"10.1177/2045125314557797","pubmed_id":"25653831","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/25653831/","substance_tags":"psilocybin","topic_tags":"Addiction,Review Article,Drug Interactions","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:25653831","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/25653831/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:25653831","source_url":"https://pubmed.ncbi.nlm.nih.gov/25653831/","doi":"10.1177/2045125314557797","pmid":"25653831","publication_date":"2015-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2540,"title":"Legal highs: staying on top of the flood of novel psychoactive substances.","authors":"Baumeister D, Tojo LM, Tracy DK","journal":"Therapeutic advances in psychopharmacology","publication_date":"2015-04-01","publication_year":2015,"doi":"10.1177/2045125314559539","pubmed_id":"26240749","openalex_id":"https://openalex.org/W2098915861","source_url":"https://pubmed.ncbi.nlm.nih.gov/26240749/","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Review Article,Animal Study,Healthcare Workers,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:26240749","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/26240749/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:26240749","source_url":"https://pubmed.ncbi.nlm.nih.gov/26240749/","doi":"10.1177/2045125314559539","pmid":"26240749","publication_date":"2015-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2513,"title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.","authors":"Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE","journal":"Therapeutic advances in psychopharmacology","publication_date":"2016-06-01","publication_year":2016,"doi":"10.1177/2045125316638008","pubmed_id":"27354908","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/27354908/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27354908","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27354908/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27354908","source_url":"https://pubmed.ncbi.nlm.nih.gov/27354908/","doi":"10.1177/2045125316638008","pmid":"27354908","publication_date":"2016-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2481,"title":"Role of psilocybin in the treatment of depression.","authors":"Mahapatra A, Gupta R","journal":"Therapeutic advances in psychopharmacology","publication_date":"2017-01-01","publication_year":2017,"doi":"10.1177/2045125316676092","pubmed_id":"28101325","openalex_id":"https://openalex.org/W2542493272","source_url":"https://pubmed.ncbi.nlm.nih.gov/28101325/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Wellbeing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:28101325","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/28101325/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:28101325","source_url":"https://pubmed.ncbi.nlm.nih.gov/28101325/","doi":"10.1177/2045125316676092","pmid":"28101325","publication_date":"2017-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2473,"title":"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.","authors":"Dos Santos RG, Bouso JC, Hallak JEC","journal":"Therapeutic advances in psychopharmacology","publication_date":"2017-04-01","publication_year":2017,"doi":"10.1177/2045125316689030","pubmed_id":"28540034","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/28540034/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Case Report","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:28540034","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/28540034/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:28540034","source_url":"https://pubmed.ncbi.nlm.nih.gov/28540034/","doi":"10.1177/2045125316689030","pmid":"28540034","publication_date":"2017-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2348,"title":"Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.","authors":"Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG","journal":"Therapeutic advances in psychopharmacology","publication_date":"2019-01-01","publication_year":2019,"doi":"10.1177/2045125319845774","pubmed_id":"31065350","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/31065350/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31065350","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31065350/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31065350","source_url":"https://pubmed.ncbi.nlm.nih.gov/31065350/","doi":"10.1177/2045125319845774","pmid":"31065350","publication_date":"2019-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2276,"title":"Psychedelic treatment of functional neurological disorder: a systematic review.","authors":"Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J","journal":"Therapeutic advances in psychopharmacology","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1177/2045125320912125","pubmed_id":"32435447","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32435447/","substance_tags":"psilocybin","topic_tags":"Systematic Review,Review Article,Healthcare Workers,Adverse Events","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32435447","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32435447/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32435447","source_url":"https://pubmed.ncbi.nlm.nih.gov/32435447/","doi":"10.1177/2045125320912125","pmid":"32435447","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2257,"title":"The therapeutic potential of microdosing psychedelics in depression.","authors":"Kuypers KPC","journal":"Therapeutic advances in psychopharmacology","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1177/2045125320950567","pubmed_id":"32922736","openalex_id":"https://openalex.org/W3082721315","source_url":"https://pubmed.ncbi.nlm.nih.gov/32922736/","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Review Article,Healthy Volunteers","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32922736","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32922736/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32922736","source_url":"https://pubmed.ncbi.nlm.nih.gov/32922736/","doi":"10.1177/2045125320950567","pmid":"32922736","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1792,"title":"Will psilocybin lose its magic in the clinical setting?","authors":"Hayes C, Wahba M, Watson S","journal":"Therapeutic advances in psychopharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1177/20451253221090822","pubmed_id":"35480296","openalex_id":"https://openalex.org/W4225982601","source_url":"https://pubmed.ncbi.nlm.nih.gov/35480296/","substance_tags":"psilocybin","topic_tags":"Depression,Review Article,Healthcare Workers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35480296","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35480296/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35480296","source_url":"https://pubmed.ncbi.nlm.nih.gov/35480296/","doi":"10.1177/20451253221090822","pmid":"35480296","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1634,"title":"Classic psychedelics, health behavior, and physical health.","authors":"Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB","journal":"Therapeutic advances in psychopharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1177/20451253221135363","pubmed_id":"36465958","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36465958/","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36465958","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36465958/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36465958","source_url":"https://pubmed.ncbi.nlm.nih.gov/36465958/","doi":"10.1177/20451253221135363","pmid":"36465958","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1479,"title":"The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.","authors":"Evens R, Schmidt ME, Majić T, Schmidt TT","journal":"Therapeutic advances in psychopharmacology","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1177/20451253231172254","pubmed_id":"37284524","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37284524/","substance_tags":"psilocybin","topic_tags":"Headache / Migraine,Wellbeing,Personality Change,Creativity,Spirituality,Systematic Review,Review Article,Adverse Events","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:37284524","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37284524/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37284524","source_url":"https://pubmed.ncbi.nlm.nih.gov/37284524/","doi":"10.1177/20451253231172254","pmid":"37284524","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1054,"title":"Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.","authors":"VanderZwaag B, Garcia-Romeu A, Garcia-Barrera MA","journal":"Therapeutic advances in psychopharmacology","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1177/20451253241264812","pubmed_id":"39132012","openalex_id":"https://openalex.org/W4401432739","source_url":"https://pubmed.ncbi.nlm.nih.gov/39132012/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Aging,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:39132012","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39132012/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39132012","source_url":"https://pubmed.ncbi.nlm.nih.gov/39132012/","doi":"10.1177/20451253241264812","pmid":"39132012","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":663,"title":"Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.","authors":"Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251342319","pubmed_id":"40492108","openalex_id":"https://openalex.org/W4411126613","source_url":"https://pubmed.ncbi.nlm.nih.gov/40492108/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Eating Disorders,End-of-Life Distress,Mechanism of Action,Review Article,Treatment-Resistant Depression,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40492108","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40492108/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40492108","source_url":"https://pubmed.ncbi.nlm.nih.gov/40492108/","doi":"10.1177/20451253251342319","pmid":"40492108","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":521,"title":"Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.","authors":"Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251372449","pubmed_id":"40933784","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40933784/","substance_tags":"psilocybin","topic_tags":"Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40933784","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40933784/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40933784","source_url":"https://pubmed.ncbi.nlm.nih.gov/40933784/","doi":"10.1177/20451253251372449","pmid":"40933784","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":483,"title":"Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.","authors":"Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251377187","pubmed_id":"41050149","openalex_id":"https://openalex.org/W4414745551","source_url":"https://pubmed.ncbi.nlm.nih.gov/41050149/","substance_tags":"psilocybin","topic_tags":"Depression,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:41050149","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41050149/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41050149","source_url":"https://pubmed.ncbi.nlm.nih.gov/41050149/","doi":"10.1177/20451253251377187","pmid":"41050149","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":473,"title":"Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.","authors":"Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251384513","pubmed_id":"41122434","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41122434/","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41122434","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41122434/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41122434","source_url":"https://pubmed.ncbi.nlm.nih.gov/41122434/","doi":"10.1177/20451253251384513","pmid":"41122434","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":435,"title":"The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.","authors":"McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251377191","pubmed_id":"41244962","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41244962/","substance_tags":"psilocybin","topic_tags":"Aging,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41244962","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41244962/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41244962","source_url":"https://pubmed.ncbi.nlm.nih.gov/41244962/","doi":"10.1177/20451253251377191","pmid":"41244962","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":404,"title":"Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.","authors":"Machado T, Rodrigues ASL, Costa J","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251397590","pubmed_id":"41356122","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41356122/","substance_tags":"psilocybin","topic_tags":"Meta-Analysis,Systematic Review,Review Article","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41356122","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41356122","source_url":"https://pubmed.ncbi.nlm.nih.gov/41356122/","doi":"10.1177/20451253251397590","pmid":"41356122","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":402,"title":"Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.","authors":"Dodds C, Dawson R, Lim A, Tye S, Nasrallah F","journal":"Therapeutic advances in psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1177/20451253251396255","pubmed_id":"41362593","openalex_id":"https://openalex.org/W4416985494","source_url":"https://pubmed.ncbi.nlm.nih.gov/41362593/","substance_tags":"psilocybin","topic_tags":"PTSD,Neuroplasticity,Mechanism of Action,Review Article,Healthcare Workers","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41362593","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41362593/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41362593","source_url":"https://pubmed.ncbi.nlm.nih.gov/41362593/","doi":"10.1177/20451253251396255","pmid":"41362593","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":22,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Therapeutic advances in psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}